Multiomics-Based Feature Extraction and Selection for the Prediction of Lung Cancer Survival
Roman Jaksik1, Kamila Szumała2, Khanh Ngoc Dinh3
1Department of Systems Biology and Engineering, Silesian University of Technology, 44-100 Gliwice, Poland.
International Journal of Molecular Sciences
|April 13, 2024
Summary
This study enhances lung cancer survival prediction using multi-omics data and machine learning. New feature extraction techniques identified key molecular features for accurate patient survival forecasting.
Area of Science:
- Oncology
- Bioinformatics
- Computational Biology
Background:
- Lung cancer poses a significant global health burden, often diagnosed late.
- Accurate prediction of patient survival is crucial for effective treatment strategies.
- Multi-omics data offers a comprehensive view of cancer's molecular complexity.
Purpose of the Study:
- To improve the accuracy of lung cancer survival prediction.
- To develop novel feature extraction and selection methods for multi-omics data.
- To identify robust molecular features associated with patient survival.
Main Methods:
- Utilized gene expression, methylation, and mutation data from TCGA and CPTAC-3 lung adenocarcinoma cohorts.
- Applied gene set aggregation as a feature extraction technique for mutation and copy number variation data.
- Developed and validated machine learning models for 2-year survival prediction using selected molecular features.
Main Results:
- Identified 32 key molecular features from TCGA data, achieving an Area Under the Curve (AUC) of 0.839 for a 2-year survival prediction model.
- Validated the model on the independent CPTAC-3 dataset, yielding an AUC of 0.815 via nested cross-validation.
- Demonstrated the robustness and generalizability of the identified features and prediction model.
Conclusions:
- The integration of multi-omics data with advanced feature engineering significantly enhances lung cancer survival prediction accuracy.
- The identified molecular features provide a strong basis for developing more precise prognostic tools.
- This approach holds promise for improving clinical decision-making and patient management in lung cancer care.


